The effect of 6 weeks of testosterone treatment on pulsatile luteinizing hormone secretion in eugonadal female-to-male transsexuals

Autor: Fedde Scheele, Peter G.A. Hompes, Louis Gooren, Jan J. Spijkstra, Taeke Spinder
Přispěvatelé: IOO, Other Research, Obstetrics and gynaecology, Internal medicine, Intensive care medicine
Rok vydání: 1991
Předmět:
Zdroj: Scheele, F, Hompes, P G A, Gooren, L J G, Spijkstra, J J & Spinder, T 1991, ' The effect of 6 weeks of testosterone treatment on pulsatile luteinizing hormone secretion in eugonadal female-to-male transsexuals ', Fertility and Sterility, vol. 55, no. 3, pp. 608-611 . https://doi.org/10.1016/S0015-0282(16)54194-6
Fertility and Sterility, 55(3), 608-611. Elsevier Inc.
ISSN: 0015-0282
Popis: Polycystic ovary disease generally is associated with elevated androgen levels and elevated luteinizing hormone (LH) levels, whereas follicle-stimulating hormone (FSH) levels are (sub)normal. To assess the role of androgens on gonadotropin secretion, we investigated the effect of 6 weeks of testosterone (T) undecanoate, 120 to 160 mg/d orally, on the parameters of the pulsatile secretion of LH in a group of six eugonadal female-to-male transsexuals with normal menstrual cycles. The treatment suppressed menstrual activity in all patients. Serum T and estrone were significantly elevated after treatment with oral T undecanoate. The parameters of the pulsatile secretion of LH were not affected by androgen administration. Levels of FSH, estradiol, and progesterone also did not change significantly.
Databáze: OpenAIRE